Working for you in Israel, Asia and the Pacific Rim

Research shows that the Asia-Pacific market for CRO services is forecast to grow 20% by 2015. A variety of factors, including large economies like China, India, Japan, and South Korea, as well as smaller markets like Malaysia and Singapore, are contributing to the growth of CROs in the region.

According to ClinicalTrails.gov, nearly 5,000 studies were underway at the end of 2011 in the 15 countries considered part of the Middle East by the FDA; including 3,190 in Israel and 874 in Turkey.

While there has been an increase in clinical trials conducted in these regions in recent years, companies that provide support need to make changes in their business models and growth strategy to align themselves with the huge opportunities that lie ahead. As a global dCRO, we recognize the expertise and local knowledge of clinical investigators, patient populations, regional regulatory nuances and cultural differences required to successfully run trials in these areas.

We are headquartered in Research Triangle Park, NC, USA, with Asian and Pacific Rim offices in Tel Aviv, Israel and New Delhi, India. Within these offices we deliver a full array of outsourced regulatory, strategic development, clinical development, and post-approval services.

Asia and Pacific Rim Services & Experience At-A-Glance: